EPA:ALCLS - Euronext Paris - Matif - FR0010425595 - Common Stock - Currency: EUR
Taking everything into account, ALCLS scores 3 out of 10 in our fundamental rating. ALCLS was compared to 65 industry peers in the Biotechnology industry. While ALCLS seems to be doing ok healthwise, there are quite some concerns on its profitability. ALCLS is valied quite expensively at the moment, while it does show a decent growth rate.
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -14.12% | ||
ROE | -41.34% | ||
ROIC | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 4.64% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 4.88 | ||
Altman-Z | -1.07 |
Industry Rank | Sector Rank | ||
---|---|---|---|
Current Ratio | 1.73 | ||
Quick Ratio | 1.73 |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
P/FCF | 7.7 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
EPA:ALCLS (6/27/2025, 7:00:00 PM)
1.256
-0.03 (-2.18%)
Industry Rank | Sector Rank | ||
---|---|---|---|
Dividend Yield | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
PE | N/A | ||
Fwd PE | N/A | ||
P/S | 2 | ||
P/FCF | 7.7 | ||
P/OCF | 6.41 | ||
P/B | 1.13 | ||
P/tB | 1.13 | ||
EV/EBITDA | N/A |
Industry Rank | Sector Rank | ||
---|---|---|---|
ROA | -14.12% | ||
ROE | -41.34% | ||
ROCE | N/A | ||
ROIC | N/A | ||
ROICexc | N/A | ||
ROICexgc | N/A | ||
OM | N/A | ||
PM (TTM) | N/A | ||
GM | 4.64% | ||
FCFM | 25.96% |
Industry Rank | Sector Rank | ||
---|---|---|---|
Debt/Equity | 0.65 | ||
Debt/FCF | 4.88 | ||
Debt/EBITDA | N/A | ||
Cap/Depr | 19.36% | ||
Cap/Sales | 5.21% | ||
Interest Coverage | N/A | ||
Cash Conversion | N/A | ||
Profit Quality | N/A | ||
Current Ratio | 1.73 | ||
Quick Ratio | 1.73 | ||
Altman-Z | -1.07 |